Cargando…
Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran
BACKGROUND: Breast cancer is the most common type of cancer amongst women throughout the world. Currently, there are various follow-up strategies implemented in Iran, which are usually dependent on clinic policies and agreement among the resident oncologists. PURPOSE: A cost-effectiveness analysis w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454675/ https://www.ncbi.nlm.nih.gov/pubmed/28125878 http://dx.doi.org/10.22034/APJCP.2016.17.12.5309 |
_version_ | 1783240876387991552 |
---|---|
author | Hatam, Nahid Ahmadloo, Niloofar Vazirzadeh, Mina Jafari, Abdossaleh Askarian, Mehrdad |
author_facet | Hatam, Nahid Ahmadloo, Niloofar Vazirzadeh, Mina Jafari, Abdossaleh Askarian, Mehrdad |
author_sort | Hatam, Nahid |
collection | PubMed |
description | BACKGROUND: Breast cancer is the most common type of cancer amongst women throughout the world. Currently, there are various follow-up strategies implemented in Iran, which are usually dependent on clinic policies and agreement among the resident oncologists. PURPOSE: A cost-effectiveness analysis was performed to assess the cost-effectiveness of intensive follow-up versus standard models for early breast cancer patients in Iran. MATERIALS AND METHODS: This cross sectional study was performed with 382 patients each in the intensive and standard groups. Costs were identified and measured from a payer perspective, including direct medical outlay. To assess the effectiveness of the two follow-up models we used a decision tree along with indicators of detection of recurrence and metastasis, calculating expected costs and effectiveness for both cases; in addition, incremental cost-effectiveness ratios were determined. RESULTS: The results of decision tree showed expected case detection rates of 0.137 and 0.018 and expected costs of US$24,494.62 and US$6,859.27, respectively, for the intensive and standard follow-up models. Tornado diagrams revealed the highest sensitivity to cost increases using the intensive follow-up model with an ICER=US$148,196.2. CONCLUSION: Overall, the results showed that the intensive follow-up method is not cost-effective when compared to the standard model. |
format | Online Article Text |
id | pubmed-5454675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-54546752017-08-28 Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran Hatam, Nahid Ahmadloo, Niloofar Vazirzadeh, Mina Jafari, Abdossaleh Askarian, Mehrdad Asian Pac J Cancer Prev Research Article BACKGROUND: Breast cancer is the most common type of cancer amongst women throughout the world. Currently, there are various follow-up strategies implemented in Iran, which are usually dependent on clinic policies and agreement among the resident oncologists. PURPOSE: A cost-effectiveness analysis was performed to assess the cost-effectiveness of intensive follow-up versus standard models for early breast cancer patients in Iran. MATERIALS AND METHODS: This cross sectional study was performed with 382 patients each in the intensive and standard groups. Costs were identified and measured from a payer perspective, including direct medical outlay. To assess the effectiveness of the two follow-up models we used a decision tree along with indicators of detection of recurrence and metastasis, calculating expected costs and effectiveness for both cases; in addition, incremental cost-effectiveness ratios were determined. RESULTS: The results of decision tree showed expected case detection rates of 0.137 and 0.018 and expected costs of US$24,494.62 and US$6,859.27, respectively, for the intensive and standard follow-up models. Tornado diagrams revealed the highest sensitivity to cost increases using the intensive follow-up model with an ICER=US$148,196.2. CONCLUSION: Overall, the results showed that the intensive follow-up method is not cost-effective when compared to the standard model. West Asia Organization for Cancer Prevention 2016 /pmc/articles/PMC5454675/ /pubmed/28125878 http://dx.doi.org/10.22034/APJCP.2016.17.12.5309 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Research Article Hatam, Nahid Ahmadloo, Niloofar Vazirzadeh, Mina Jafari, Abdossaleh Askarian, Mehrdad Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran |
title | Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran |
title_full | Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran |
title_fullStr | Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran |
title_full_unstemmed | Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran |
title_short | Cost-Effectiveness of Intensive Vs. Standard Follow-Up Models for Patients with Breast Cancer in Shiraz, Iran |
title_sort | cost-effectiveness of intensive vs. standard follow-up models for patients with breast cancer in shiraz, iran |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454675/ https://www.ncbi.nlm.nih.gov/pubmed/28125878 http://dx.doi.org/10.22034/APJCP.2016.17.12.5309 |
work_keys_str_mv | AT hatamnahid costeffectivenessofintensivevsstandardfollowupmodelsforpatientswithbreastcancerinshiraziran AT ahmadlooniloofar costeffectivenessofintensivevsstandardfollowupmodelsforpatientswithbreastcancerinshiraziran AT vazirzadehmina costeffectivenessofintensivevsstandardfollowupmodelsforpatientswithbreastcancerinshiraziran AT jafariabdossaleh costeffectivenessofintensivevsstandardfollowupmodelsforpatientswithbreastcancerinshiraziran AT askarianmehrdad costeffectivenessofintensivevsstandardfollowupmodelsforpatientswithbreastcancerinshiraziran |